Dr. Lynch Accepts His 'Giants of Cancer Care' Award

Thomas J. Lynch, Jr., MD, from the Yale Cancer Center, pioneered the use of molecular testing for EGFR mutations in lung cancer. In July 2013, he was honored by OncLive as one of the "Giants of Cancer Care."

Thomas J. Lynch, Jr., MD, from the Yale Cancer Center, pioneered the use of molecular testing for EGFR mutations in lung cancer. In July 2013, he was honored by OncLive as one of the "Giants of Cancer Care."

The 2013 Giants of Cancer Care was conducted at the Hyatt Regency in Huntington Beach, California.

For more information on the Giants of Cancer Care, visit giants.onclive.com

Related Content:

Yale Cancer CenterOncLive TVLung Cancer
OncLive’s September Roundup of Key FDA Approvals in Oncology
Patient-Centered Discussions Will Be Critical to Navigate Treatment Selection in EGFR+ NSCLC
Dr Saad on the Continued Investigation of Darolutamide Plus ADT in mHSPC